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Abstract Melanin pigments are substances produced
by a broad variety of pathogenic microorganisms,
including bacteria, fungi, and helminths. Microbes
predominantly produce melanin pigment via tyrosin-
ases, laccases, catecholases, and the polyketide
synthase pathway. In fungi, melanin is deposited in
the cell wall and cytoplasm, and melanin particles
(‘‘ghosts’’) can be isolated from these fungi that have
the same size and shape of the original cells. Melanin
has been reported in several human pathogenic
dimorphic fungi including Paracoccidioides brasili-
ensis, Sporothrix schenckii, Histoplasma capsulatum,
Blastomyces dermatitidis, and Coccidioides posadasii.
Melanization appears to contribute to virulence by
reducing the susceptibility of melanized fungi to host
defense mechanisms and antifungal drugs.
Keywords Paracoccidioides brasiliensis 
Melanin  Dimorphic fungi  Susceptibility 
Pathogenesis
Introduction
Melanin pigments are multifunctional polymers ubiq-
uitous in nature as they are produced by a remarkable
variety of organisms, including bacteria, fungi,
plants, and animals. Melanins are negatively charged,
hydrophobic, and high molecular-weight compounds,
insoluble in aqueous and organic solvents and
consequently are difficult to study by conventional
biochemical and biophysical techniques. The knowl-
edge about the structure of this pigment is, therefore,
limited [1, 2]. They are formed by the oxidative
polymerization of phenolic and/or indolic compounds
and usually are dark brown or black, although
melanin pigments with other colors also exist [1]. A
discussion on the contribution of melanin to micro-
bial pathogenesis has attracted considerable interest,
with melanin being focused on as a putative virulence
factor in fungi.
Although the synthesis of melanin in mammals is
typically catalyzed by tyrosinases [3], microbes
generally use the polyketide synthase pathway and/
or phenoloxidases (like laccases) [4]. Recognized
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human fungal pathogens that form melanin precur-
sors by the polyketide pathway include Exophiala
(Wangiella) dermatitidis, Sporothrix schenckii,
Alternaria alternata, Cladosporium carionii, Fonse-
caea pedrosoi, Aspergillus niger, A. nidulans, and
A. fumigatus [5–9]. The production of DOPA-mela-
nin via phenoloxidases in fungi has also raised
scientific interest [10]. The synthesis of melanin in
fungi by the DOPA-melanin pathway, also known
as eumelanin, requires the presence of exogenous
substrate in the form of certain o-diphenolic and
p-diphenolic compounds, such as 3,4 dihydroxyphen-
ylalanine (L-DOPA) [11]. The pathogenic fungi
investigated in the production of DOPA-melanins
via polyphenoloxidase (a laccase) include many
model organisms such as Cryptococcus neoformans
[12, 13], Paracoccidioides brasiliensis [14, 15],
Histoplasma capsulatum [16], Blastomyces dermatit-
idis [17], Candida albicans [18], and Coccidioides
posadasii [19].
Treatment of melanized cells by enzymatic diges-
tion of the cell wall, proteolysis, chloroform
extraction, and boiling in concentrated HCl results
in the recovery of melanin ghosts [14, 20]. Atomic-
force microscopy and scanning electron microscopy
images reveal that the surface of melanin ghosts
derived from melanized C. neoformans cells is
composed of discrete granules with roughly uniform
dimensions, which corresponds to information known
for other melanins [21]. Nuclear magnetic resonance
cryoporometry shows that melanin ghosts contain
pores with diameters between 1 and 4 nm, in addition
to a small number of pores with diameters near
30 nm [21]. Additionally, elution of graded dextrans
has revealed pores in melanized and nonmelanized
cells of 4.0 and 10.6 nm, respectively [22].
Some fungi like C. neoformans and several
molds can produce melanin in the soil, and this
characteristic may provide increased resistance to
the environmental stressors [23, 24]. Melanized
C. neoformans is more resistant to ingestion by
environmental amoeboid [25] or nematode [26]
species. Melanins also protect fungi from hydrolytic
enzymes [27], UV, solar or gamma radiation
[28, 29], extreme temperatures [30], and heavy
metals and several other toxic compounds [reviewed
in 24].
Melanins are immunologically active, however
little is known about their relationship with immune
systems. Some authors have shown that melanins
affect macrophages and reduce proinflammatory
cytokines [14, 31, 32]. For example, melanized
C. neoformans cells can down-regulate the afferent
immune response [33]. Melanization C. neoformans
or yeast melanized in vivo elicits inflammatory
changes different from nonmelanized or laccase-
deficient cells and also interfere with phagocytosis
of encapsulated yeast cells [34]. Melanin-binding
antibody can also modify infection and melanin-
binding antibodies have been isolated from mice with
experimental cryptococcosis and humans infected
with F. pedrosoi [8, 31]. Melanin-binding antibodies
can influence the phagocytosis and intracellular death
of diverse fungi [14].
Given the importance of melanin on fungal
pathogenesis, it is timely to review recent studies
that have expanded our understanding of the impact
of melanin production on dimorphic fungi during the
infection, the host immune defense, and the resis-
tance to antimicrobial drugs.
Mechanism by which melanin pigments contribute
to virulence in human thermally dimorphic fungi
Paracoccidioides brasiliensis
Paracoccidioides brasiliensis is the agent of the
human systemic disease paracoccidioidomycosis,
which affects individuals in endemic areas extending
from Argentina to Central America. It is the most
prevalent deep mycosis in Latin America and about
80% of diagnosed patients are from Brazil. Rural
workers are the main group at risk for infection, but
dwellers of urban centers located on the route of
migration movements are also affected. One estima-
tive suggests that ten million people are infected with
P. brasiliensis and that up to 2% may develop disease
[35–37]. Paracoccidioidomycosis is the 8th most
common cause of death due to chronic/recurrent
infections and parasitic diseases in Brazil [38].
Infection is thought to occur due to inhalation of
conidia that subsequently transform into yeast forms
within the lung. Although acquisition of the fungus
typically results in asymptomatic infection, infection
can progress to acute, subacute, and chronic clini-
cal forms of disease [39]. The virulence of the
fungi is directly related to the host immune cellular
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resistance. However, there are differences in viru-
lence between fungal isolates based on a number of
attributes, such as melanin, which appear to contrib-
ute to pathogenicity.
The ability of P. brasiliensis to make melanin
pigments was first described by Go´mez et al. [15]
(Fig. 1). The authors recovered pigmented particles
after chemical and enzymatic treatment of conidia
and yeasts grown in vitro (on water agar for conidia
and in the presence of L-DOPA with yeasts). They
also recovered yeast shaped melanin-like particles
from infected mouse tissue after chemical and
enzymatic treatment. Particles collected from cells
in vitro and in vivo were reactive with antibody to
melanin. A laccase-like activity was detected in
protein extracts of P. brasiliensis that was implicated
in the enzymatic synthesis of melanin in yeast cells.
Additionally, in vitro conidial melanization is quite
significant since conidia become pigmented when
suspended in pure water indicating a capacity to
synthesize melanin-like pigment in the absence of
L-DOPA, which would require the fungus to either
synthesize its own phenolic precursors for use via
laccase or to utilize a different mechanism, such as
the polyketide synthesis pathway, to produce melanin
[15].
Relatively, little is known about the localization of
melanin in human pathogenic fungi but it has been
described in intracellular and/or extracellular (e.g.,
outside cell membrane) spaces. Some fungal melanin
is found as part of the cell wall, often recognizable as
a distinct and fairly sharply defined outer layer, and
some melanin has been found in association with a
fibrillar matrix projecting outward from the cell wall
of many fungi. For instance, H. capsulatum yeast
cells produce melanin in their cell wall and also have
granules of melanin extending from their outer cell
wall [16]. Similarly, pigmented granules have been
identified on the surface of S. schenckii yeast [5]. In
contrast, in C. neoformans, exogenous L-DOPA is
used for the synthesis of a melanin layer next to the
cell membrane and internal region of the cell wall
[40]. In contrast, C. albicans produces small spheres
of melanin and presumably secretes them as compo-
nents of biofilm [18]. For P. brasiliensis, scanning
electron microscopy reveals that melanized and
nonmelanized yeast cells have a smooth surface with
no major difference between them, but analysis by
transmission electron micrographs shows electron-
dense granules distributed throughout the cytoplasm
and on the cell surface [14].
The ability of melanin to protect microbes from
host defense is relevant to antimicrobial therapy
because the clinical efficacies of some antimicrobial
drugs are complemented by host immune defense
mechanisms (reviewed by [24]). Table 1 summarizes
the principal differences observed between melanized
and nonmelanized yeast cells against host immune
defenses and susceptibility to antifungal compounds.
Melanized P. brasiliensis yeast cells increase resis-
tance to phagocytosis [14]. Since melanins are
charged polymers [41] their presence in the cell wall
can alter the fungal cell surface charge as shown to
occur with melanization in C. neoformans [42],
Fig. 1 Light microscopy of
P. brasiliensis yeast cells
grown in liquid medium
without (A) and with
(B) L-DOPA. Original
magnification 100·
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which may contribute to inhibition of phagocytosis.
Additionally, melanin can stimulate humoral immune
responses. Mice immunized with melanin ghosts
from C. neoformans produce specific antibodies
against melanin [31, 43]. Interestingly although
polyclonal antibodies against P. brasiliensis melanin
can increase phagocytosis of melanized yeast cells by
macrophages-like cell lines J774.16 and MH-S (per-
itoneal and alveolar macrophages, respectively)
in vitro [44], polyclonal antibodies against P. brasil-
iensis non-melanin, cell wall antigens do not enhance
the uptake of melanized yeast cells [14]. This
indicates that melanin interferes with the binding of
diverse antibodies resulting in a general reduction in
the internalization of melanized cells [14].
In addition to reducing ingestion, melanization
protects P. brasiliensis against killing by macro-
phages [14]. Similarly, melanin production in
C. neoformans [45], F. pedrosoi [46], S. schenckii
[5] and Exophiala spp. [47] enhances resistance to
killing by phagocytic cells. The resistance of melan-
ized yeast cells of P. brasiliensis to internalization by
macrophages in vitro and their increased intracellular
survival if ingested can explain the higher fungal
burden in the lung of Balb/c mice infected intrat-
racheally with melanized cells, when compared with
nonmelanized P. brasiliensis [44].
The mechanism of increased survival of pig-
mented P. brasiliensis yeast cells is in part due to the
fact that melanization protects P. brasiliensis against
injury mediated by nitrogen- or oxygen-derived free
radicals [44] and also enhances resistance to H2O2
and hypochlorite as has similarly been shown in
C. neoformans, Aspergillus spp., and S. schenckii
(Reviewed in [24, 28]). Melanins are highly effective
scavengers of free radicals [48] and have electron
transfer properties [49]. Electron transfer from free
radical species generated in solution to C. neofor-
mans melanin has been demonstrated by electron
spin resonance spectroscopy [45] and similar spectra
have also been generated with melanins from
H. capsulatum, S. schenckii, P. brasiliensis, and
Pneumocystis spp. (Reviewed in [24, 28]).
Melanin is an antifungal resistance factor, given
its ability to reduce the susceptibilities of melanized
cells to antifungal drugs [50]. Notably, there is no
evidence for the involvement of melanin in drug
efflux pumps or in alterations in the synthesis of
ergosterol or glucans in the fungal cell wall or cell
membrane structures (reviewed in [24]). Melaniza-
tion of P. brasiliensis yeast cells does not affect the
cytotoxicity of amphotericin B, ketoconazole, fluco-
nazole, itraconazole, sulfamethoxazole as measured
by standard CLSI broth macrodilution procedures for
assessing the susceptibility of yeast cells to antifun-
gal drugs [14]. Similar results have previously
been observed with melanized and nonmelanized
C. neoformans and H. capsulatum [51]. However, an
increased resistance of P. brasiliensis melanized cells
to antifungal drugs mainly amphotericin B, and less
pronounced with ketoconazole, fluconazole, itraco-
nazole, and sulfamethoxazole, has been shown using
a time-kill assay [14]. The killing assay has also
shown that melanized C. neoformans and H. capsu-
latum are less susceptibility to amphotericin B and
caspofungin, but melanization does not affect cell
resistance when fluconazole or itraconazole is used
[51].
Laccase is an important virulence factor in many
pathogenic fungi. Two different methods have been
used to demonstrate that P. brasiliensis produces a
laccase-like enzyme [14, 15]. In spite of considerable
efforts by several investigators, many aspects of the
nature of laccase remain unclear. In C. neoformans,
the ability of laccase to produce melanin pigments and
prevention of iron-dependent Fenton reaction prod-
ucts results in enhanced dissemination of yeast forms
to the brain, thus strongly correlating the enzyme with
virulence [52, 53]. In C. neoformans, laccase appears
to localize predominantly to the outer region of the
cell wall where it can interact more directly with
extracellullar substances and host immune products
without the need for ancillary membrane or cytosolic
transporters [54]. For example, oxidation of catechol-
amines on the outermost region of the cell wall lessens
the exposure to oxidized dopamine products, which
are cytotoxic in other systems [55]. Besides the
oxidative effects on catecholamine, recombinant
cryptococcal laccase exhibits iron oxidation activity
converting Fe2+ to Fe3+. Iron oxidase activity of
laccase may protect C. neoformans from alveolar
macrophages by oxidation of phagosomal iron to Fe3+
with a resulting decrease in hydroxyl radical forma-
tion [56]. In addition, laccase activity has been found
to be a marker of stress, as the induction of laccase
correlated with substrate starvation and presence of
potentially toxic metals [57]. It is currently not known
whether the P. brasiliensis laccase contributes to
334 Mycopathologia (2008) 165:331–339
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virulence by mechanisms other than the production of
melanin.
Other fungal species
Sporothrix schenckii
Sporothrix schenckii is a thermally dimorphic fungus
frequently associated with plants and soil and it is the
causative agent of sporotrichosis, an important cuta-
neous and subcutaneous human and animal pathogen
[58, 59]. The mycelial phase predominates in the
environment whereas yeast-like forms develop in
infected human and animal tissues [60]. Most cases
of sporotrichosis are localized to the skin and
subcutaneous tissues, although dissemination to
osteoarticular structures and viscera may occur in
both healthy and immunosuppressed individuals,
particularly individuals with AIDS [61].
Table 1 Melanin as virulence factor of P. brasiliensis—general effects and virulence
Characteristics P. brasiliensis Reference
Melanized Nonmelanized
Morphologya
Hyphae Absent o [14, 15]
Conidia Present o
yeast Present o
Phagocytosisb
Alveolar MØ 3.9 ± 0.5 5.8 ± 0.8 [14]
Peritoneal MØ 4.1 ± 0.4 12.3 ± 0.5
Adherencec
Alveolar MØ 11.2 ± 1 8.1 ± 0.8 [14]
Peritoneal MØ 3.2 ± 0.9 0.7 ± 0.2
MICd No difference No difference [14]
Killing assaye Less susceptible Susceptible [14]
Antifungal activity of MØf
Cfu after 6 h 4,583 ± 117 8,000 ± 408 [14]
Cfu after 12 h 3,666 ± 169 4,166 ± 236
In vivo—cfu g/tissueg 30,000 ± 400 19,000 ± 800 [44]
In vitro resistance to oxidantsh Less susceptible Susceptible [44]
a Detection of presence or absence of melanin in vitro or in vivo
b Phagocytosis of melanized or nonmelanized yeast cells after 24 h of exposition to mice macrophage-like MH-S (alveolar) and
macrophage-like J774.16 (peritoneal)
c Laterally adherent noninternalized yeast cells after 24 h of exposition to mice macrophage-like MH-S (alveolar) and macrophage-
like J774.16 (peritoneal)
d Minimal inhibitory concentration of melanized and nonmelanized yeast cells to amphotericin b, ketoconazole, fluconazole,
itraconazole, and sulfamethoxazole
e Antifungal killing assay of melanized and nonmelanized yeast cells to amphotericin b, ketoconazole, fluconazole, itraconazole, and
sulfamethoxazole
f Antifungal activity of macrophages after 6 and 24 h of incubation on melanized and nonmelanized yeast cells with J774.16
previously treated with IFN-c
g Cfu from lungs of Balb/c mice intratracheally infected with 3 · 105 yeast cells of melanized and nonmelanized P. brasiliensis after
30 days of infection
h In vitro exposition of melanized and nonmelanized yeast cells to chemically generated NO, oxygen-derivated oxidants, chloride-
free sodium hypochlorite, and hydrogen peroxide
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Existing data suggests that the conidia of
S. schenckii produce melanin compounds via a
1,8-dihydroxynaphthalene pentaketide pathway [5].
On the selective medium Mycosel, S. schenckii
produces visibly pigmented conidia, which are not
observed when brain heart infusion and minimal
broth are used; hyphae are generally not melanized
[62]. However, by using techniques for production of
melanin ghosts, melanin-like particles can be recov-
ered from cells grown on Mycosel and minimal broth
[63]. Monoclonal antibodies against melanin of
S. schenckii have been generated and used to detect
melanin or melanin-like compounds in conidia
in vitro, and in yeast cells in vitro and in vivo [62].
Melanized S. schenckii yeast is less susceptible to
killing by chemically generated oxygen- and nitro-
gen-derived radicals and UV light than melanin-
deficient cells [5]. S. schenckii melanin also interferes
with yeast cell phagocytosis and diminishes the
respiratory burst mediated by human monocytes and
murine macrophages [5]. Melanized conidia are more
resistant to phagocytosis and killing than nonmelan-
ized conidia and melanin has been associated with
scavenging oxygen and nitrogen species [5].
Histoplasma capsulatum
Histoplasma capsulatum is a thermally dimorphic
fungus that occurs most commonly in North and
Central America, but the microorganism exists in
many diverse areas around the world. Individuals at
greatest risk for histoplasmosis are those who have
occupational or recreational activities that disrupt the
soil, or those who are in contact with accumulated dirt
and guano in old buildings, bridges or caves where bats
have roosted [reviewed in 63]. Every year, hundreds of
thousands of individuals in the US and Central
America are infected with H. capsulatum. The vast
majority of infected persons are either asymptomatic
or have a very mild disease that is never recognized as
histoplasmosis [reviewed in 63]. Histoplasmosis may,
however, progress to life-threatening systemic dis-
ease particularly in immuno-compromised individuals
[64, 65].
H. capsulatum conidia, but not hyphae, produce
melanin in minimal medium without the addition of
phenolic substrate [16]. Yeast cells also produce
melanin, but only when cultivated with phenolic
compounds such as L-DOPA or (–)-epinephrine [16].
Scanning electron microscopy demonstrates that
melanized conidia and yeast cells grown with
L-DOPA formed tufts on the cell surface whereas
cells grown in the absence of L-DOPA are smooth
[16]. Transmission electron microscopy of melanized
yeast cells demonstrated that the cell wall is coated
with electron-dense granules [16]. Furthermore, the
presence of laccase-like activity has been observed in
cytoplasmatic extracts of H. capsulatum incubated
with L-DOPA [16].
Melanization of H. capsulatum has been confirmed
by the binding of melanin-specific antibodies to yeast
cell walls in infected tissue and the recovery of
melanin-like yeast-shaped particles from infected
lungs subjected to treatment with acid, denaturing
agents and enzymes [16]. Although the CLSI mini-
mal inhibitory concentration (MIC) test with
amphotericin B and caspofungin fail to detect differ-
ences between melanized and nonmelanized cells,
time-kill assays show that melanized cells are signif-
icantly less susceptible to amphotericin B and
caspofungin [51]. In contrast, no differences were
found using fluconazole or itraconazole. The phe-
nomenon of resistance to amphotericin B and
caspofungin could be explained by the binding of
the drugs to melanin which mitigates their antifungal
actions [51].
Blastomyces dermatitidis
Blastomyces dermatitidis is a thermally dimorphic
fungus endemic to the central USA that affects
humans and animals. The fungus occurs in the
environment as mycelia and forms yeast cells after
infecting host tissue. Individuals exposed to the
fungus may have an asymptomatic infection or can
develop fatal pneumonia even in immunocompetent
individuals [66]. In individuals with impaired immu-
nity, the fungus behaves as an opportunistic pathogen
after latent infection and can cause widely dissemi-
nation disease [67].
A melanin-like pigment from B. dermatitidis
occurs in conidia, but not hyphae, is produced by
mycelium grown on defined chemical medium or
brain heart infusion, whereas yeast cells only become
pigmented when grown in media supplemented with
L-DOPA [17]. Melanin-binding monoclonal antibody
336 Mycopathologia (2008) 165:331–339
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avidly labels particles isolated from B. dermatitidis
conidia and yeast by serial treatment with enzymes
and hot acid [17]. Additionally, tissue sections of
lung from a dog with blastomycosis also reacted with
the antibody, indicating that this fungus melanizes
in vivo [17]. Consistent with previously described
studies, there are no differences in the MIC of
melanized and nonmelanized yeast cells for
amphotericin B, itraconazole and voriconazole, but
time-kill assays demonstrate that melanized yeast
cells are significantly less susceptible to amphotericin
B [17].
Coccidioides posadasii
Coccidioides posadasii is a thermally dimorphic
endemic fungus in USA, Mexico, Central, and South
America [68]. It grows as mycelia in desert and
semiarid soils and disturbances in the soil facilitate
the dispersal of arthroconidia, which are the infec-
tious propagules. Once inhaled, the arthroconidia
convert into the parasitic spherule/endospore phase in
tissue [69]. Individuals exposed to this fungus may be
asymptomatic, but half of immunologically compe-
tent individuals develop an atypical pneumonia
characterized by cough, fever, and pleuritic pain
often accompanied by rashes, sore throat, headache,
arthralgia, myalgia or anorexia [69].
C. posadasii produces melanin. Utilizing the
techniques described for other melanized pathogenic
fungi, it was observed that the saprobic phase of C.
posadasii produces melanized arthroconidia but not
hyphae [19]. Melanin particles from arthroconidia
and intact heat-killed arthroconidia were recognized
by melanin-binding monoclonal antibody, indicating
the presence of melanin or melanin-like deposits in
the residual cell wall material [19]. The parasitic
phase was also analyzed. Melanin particles, similar
to intact spherule propagules, were obtained after
subjecting infected tissues to denaturing enzymes
and hot HCl. Additionally, lung tissue immunoflu-
orescence revealed that only endospores within the
spherules in the tissue sections reacted with mela-
nin-binding monoclonal antibody with the cell wall
of spherules being poorly labeled [19]. Also, intact
spherules grown in vitro were not labeled, however
spherules grown in vitro devoid of the lipid-rich,
membranous spherule outer wall were readily
labeled by melanin-binding antibody [19]. Hence,
the lipid-rich component of C. posadasii effectively
blocked reactivity of the melanin-binding antibody,
which may affect the pigment’s engagement with
host effector cells.
Conclusions
Production of melanin is widespread among micro-
organisms. In dimorphic fungi like P. brasiliensis,
S. schenckii, H. capsulatum, B. dermatitidis, and
C. posadasii, melanin production may promote
fungal survival in different environments, augment
their resistance to immune effector responses in the
infected host, and reduce their susceptibility to
antifungal drugs.
Dimorphic fungi appear to produce DHN-melanin
in conidia/arthroconidia in nature primarily via a
polyketide synthetase pathway. Interestingly, there is
an absence of this pigment in hyphae. Melanin
production and its effects on the parasitism by yeast
cells or spherules/endospores require specific sub-
strates as shown in vitro by addition of L-DOPA or
other suitable phenolic compounds in a process
mediated by laccase-like enzymes. Melanin and
laccase affect the virulence capacity of pathogenic
microorganisms. Melanins are a challenge to the
defense mechanisms of the hosts, but they are also
targets for alternative antimicrobial strategies as
exemplified by the fact that passive administration
of monoclonal antibodies against C. neoformans
melanin can prolong the survival of and reduce the
fungal burden in C. neoformans-infected mice [43]. A
similar result was observed by administration of
glyphosate to mice infected with C. neoformans
resulting in delayed melanization of yeast cells
in vivo and prolonged mouse survival [70].
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